Skip to main content
. 2022 Mar 29;10:e13212. doi: 10.7717/peerj.13212

Table 2. Univariate Cox regression analysis of all-cause mortality.

Variable Change HR (95% CI) p value
Gender Female vs. Male 1.30 (0.72–2.35) 0.388
Family history of HCM Yes vs. no 0.82 (0.30–2.31) 0.713
Family history of SCD Yes vs. no 2.00 (0.72–5.61) 0.186
Chest pain Yes vs. no 0.73 (0.40–1.32) 0.300
Palpitation Yes vs. no 0.74 (0.40–1.37) 0.334
Syncope/pre-syncope Yes vs. no 0.69 (0.36–1.34) 0.277
Dyspnea Yes vs. no 2.51 (1.27–4.97) 0.008*
Hypertension Yes vs. no 1.02 (0.54–1.93) 0.943
Diabetes Yes vs. no 1.36 (0.54–3.46) 0.515
Prior TE Yes vs. no 2.19 (0.78–6.14) 0.134
Vascular disease Yes vs. no 1.38 (0.49–3.87) 0.544
Atrial fibrillation Yes vs. no 2.57 (1.38–4.79) 0.003*
Aspirin Yes vs. no 1.15 (0.55–2.39) 0.714
Clopidogrel Yes vs. no 0.45 (0.06–3.29) 0.434
β-blocker Yes vs. no 0.62 (0.33–1.16) 0.138
ACE inhibitor or ARB Yes vs. no 0.57 (0.23–1.45) 0.240
Procedures
Alcohol septal ablation Alcohol septal ablation vs. none 0.50 (0.12–2.06) 0.335
Septal myectomy Septal myectomy vs. none 1.63 (0.22–11.9) 0.631
Devices
Pacemaker Pacemaker vs. none 1.60 (0.49-5.19) 0.431
ICD ICD vs. none 0.50 (0.12–2.09) 0.345
Resting LVOTG ≥ 30 mm Hg Yes vs. no 1.38 (0.76–2.50) 0.283
Age (years) Per 1-SD increase 1.51 (1.09–2.11) 0.015*
Hemoglobin (g/L) Per 1-SD increase 0.67 (0.51–0.88) 0.005*
WBCC (109/L) Per 1-SD increase 0.87 (0.62–1.23) 0.439
Neutrophil (109/L) Per 1-SD increase 1.04 (0.77–1.39) 0.815
Lymphocyte (109/L) Per 1-SD increase 0.61 (0.43–0.84) 0.003*
Monocyte (109/L) Per 1-SD increase 1.12 (0.83–1.50) 0.470
TG (mmol/L) Per 1-SD increase 0.53 (0.32–0.89) 0.016*
HDL-C (mmol/L) Per 1-SD increase 0.96 (0.71–1.30) 0.803
LDL-C (mmol/L) Per 1-SD increase 0.64 (0.47–0.88) 0.006*
LVEDD (mm) Per 1-SD increase 0.85 (0.61–1.19) 0.350
LA diameter (mm) Per 1-SD increase 1.42 (1.08–1.86) 0.012*
MWT (mm) Per 1-SD increase 1.03 (0.77–1.38) 0.858
LVEF (%) Per 1-SD increase 0.77 (0.60–0.99) 0.044*

Notes.

HR
hazard ratio
CI
confidence interval

Other abbreviations as in Table 1.

*

Significant p values.